Dietary fibers and cardiometabolic diseases.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 3291975)

Published in Int J Mol Sci on February 02, 2012

Authors

Graziano Riccioni1, Valeriana Sblendorio, Eugenio Gemello, Barbara Di Bello, Luca Scotti, Salvatore Cusenza, Nicolantonio D'Orazio

Author Affiliations

1: Cardiology Unit, San Camillo de Lellis Hospital, Manfredonia, Foggia, 71043, Italy.

Articles citing this

Dietary habits in patients with ischemic stroke: a case-control study. PLoS One (2014) 0.75

Articles cited by this

Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care (2008) 9.34

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet (1989) 9.27

Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation (1999) 8.13

A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch Intern Med (1992) 7.38

Optimal diets for prevention of coronary heart disease. JAMA (2002) 7.24

Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev (2001) 7.19

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet (1981) 7.05

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet (1990) 6.49

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One (2010) 6.48

Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr (2004) 4.29

Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA (1996) 4.29

Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med (2007) 3.91

Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr (1999) 3.89

Prebiotic effects: metabolic and health benefits. Br J Nutr (2010) 3.49

Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr (2003) 3.38

Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA (1999) 3.34

Associations of whole-grain, refined-grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2003) 2.76

Dietary fiber and body weight. Nutrition (2005) 2.71

Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med (2004) 2.60

Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med (2011) 2.59

Prospective study of major dietary patterns and stroke risk in women. Stroke (2004) 2.52

Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med (2007) 2.47

Why whole grains are protective: biological mechanisms. Proc Nutr Soc (2003) 2.47

Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc (2008) 2.35

Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr (2002) 2.23

Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr (2002) 2.21

New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre? Nutr Res Rev (2010) 2.20

Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men. Am J Clin Nutr (2004) 2.14

Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Circulation (1996) 2.13

Whole grains and human health. Nutr Res Rev (2004) 2.12

A prospective study of dietary fiber intake and risk of cardiovascular disease among women. J Am Coll Cardiol (2002) 2.10

Plausible mechanisms for the protectiveness of whole grains. Am J Clin Nutr (1999) 2.06

Cereal grains, legumes and diabetes. Eur J Clin Nutr (2004) 1.77

Ischemic heart disease and dietary fiber. Am J Clin Nutr (1972) 1.76

Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res (2006) 1.68

Glycemic index, glycemic load, and cereal fiber intake and risk of type 2 diabetes in US black women. Arch Intern Med (2007) 1.67

Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA (2003) 1.54

Cereal grains and legumes in the prevention of coronary heart disease and stroke: a review of the literature. Eur J Clin Nutr (2006) 1.49

Whole grain intake and cardiovascular disease: a review. Curr Atheroscler Rep (2004) 1.49

Whole grain consumption and risk of ischemic stroke in women: A prospective study. JAMA (2000) 1.47

Dietary fiber intake and reduced risk of coronary heart disease in US men and women: the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med (2003) 1.43

Whole-grain intake and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr (2003) 1.41

Food patterns and cardiovascular disease risk factors: the Swedish INTERGENE research program. Am J Clin Nutr (2008) 1.40

Cereal grains and coronary heart disease. Eur J Clin Nutr (2002) 1.36

Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides. Crit Rev Food Sci Nutr (2011) 1.36

Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA (1999) 1.26

Intake of refined carbohydrates and whole grain foods in relation to risk of type 2 diabetes mellitus and coronary heart disease. J Am Coll Nutr (2002) 1.25

The role of whole grains in disease prevention. J Am Diet Assoc (2001) 1.22

Vegetarian diets and weight status. Nutr Rev (2006) 1.19

Nutraceuticals and atherosclerosis: human trials. Cardiovasc Ther (2010) 1.18

Diet and incident ischaemic heart disease: the Caerphilly Study. Br J Nutr (1993) 1.16

High-fiber rye bread and insulin secretion and sensitivity in healthy postmenopausal women. Am J Clin Nutr (2003) 1.16

Dietary fiber intake in relation to coronary heart disease and all-cause mortality over 40 y: the Zutphen Study. Am J Clin Nutr (2008) 1.13

Is whole grain intake associated with reduced total and cause-specific death rates in older women? The Iowa Women's Health Study. Am J Public Health (1999) 1.11

Dietary fibre: influence on body weight, glycemic control and plasma cholesterol profile. Nutr Hosp (2010) 1.11

Whole grains protect against atherosclerotic cardiovascular disease. Proc Nutr Soc (2003) 1.09

Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol (2001) 1.08

Fiber from whole grains, but not refined grains, is inversely associated with all-cause mortality in older women: the Iowa women's health study. J Am Coll Nutr (2000) 1.07

Fermentation of resistant rice starch produces propionate reducing serum and hepatic cholesterol in rats. J Nutr (2000) 1.07

Relationship between molecular structure of cereal dietary fiber and health effects: focus on glucose/insulin response and gut health. Nutr Rev (2011) 1.06

Retracted Translational research into gut microbiota: new horizons in obesity treatment. Arq Bras Endocrinol Metabol (2009) 1.06

Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr (2002) 1.05

Pulses and lipaemia, short- and long-term effect: potential in the prevention of cardiovascular disease. Br J Nutr (2002) 1.05

Dietary fiber in the prevention and treatment of metabolic syndrome: a review. Crit Rev Food Sci Nutr (2008) 1.01

Dietary fiber and progression of atherosclerosis: the Los Angeles Atherosclerosis Study. Am J Clin Nutr (2003) 1.00

Fiber, lipids, and coronary heart disease. A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation (1997) 1.00

Propionate inhibits incorporation of colonic [1,2-13C]acetate into plasma lipids in humans. Am J Clin Nutr (1995) 0.92

Whole grain foods and heart disease risk. J Am Coll Nutr (2000) 0.90

Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta-analysis. J Nutr (1997) 0.89

Effect of one week of fibre supplementation on hunger and satiety ratings and energy intake. Appetite (1997) 0.86

Fiber intake of normal weight, moderately obese and severely obese subjects. Obes Res (1995) 0.86

The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction trial (DART). Eur J Clin Nutr (2002) 0.84

Dietary fibre intake and clinical indices in the French Supplementation en Vitamines et Minéraux AntioXydants (SU.VI.MAX) adult cohort. Proc Nutr Soc (2003) 0.79

Dietary fiber: chemistry, analysis, and properties. Adv Food Res (1987) 0.77

The effect of non-starch polysaccharide supplementation on circulating bile acids, hormone and metabolite levels following a fat meal in human subjects. Br J Nutr (1993) 0.76

Articles by these authors

Fucoxantin: a treasure from the sea. Mar Drugs (2012) 1.21

The anesthetic conserving device compared with conventional circle system used under different flow conditions for inhaled anesthesia. Anesth Analg (2003) 1.09

Advances in therapy with antileukotriene drugs. Ann Clin Lab Sci (2004) 1.07

Marine carotenoids and cardiovascular risk markers. Mar Drugs (2011) 1.03

Potential therapeutic effects of natural heme oxygenase-1 inducers in cardiovascular diseases. Antioxid Redox Signal (2012) 1.02

Carotenoids and vitamins C and E in the prevention of cardiovascular disease. Int J Vitam Nutr Res (2012) 1.01

Marine bioactives: pharmacological properties and potential applications against inflammatory diseases. Mar Drugs (2012) 1.00

Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests. J Appl Physiol (1985) (2009) 1.00

Role of dietary and endogenous antioxidants in diabetes. Crit Rev Food Sci Nutr (2014) 1.00

Mediterranean diet and cardiovascular risk factors: a systematic review. Crit Rev Food Sci Nutr (2014) 0.97

Novel phytonutrient contributors to antioxidant protection against cardiovascular disease. Nutrition (2012) 0.97

The role of the antioxidant vitamin supplementation in the prevention of cardiovascular diseases. Expert Opin Investig Drugs (2007) 0.92

Intravenous use of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. Arch Orthop Trauma Surg (2014) 0.92

Leukotrienes in atherosclerosis: new target insights and future therapy perspectives. Mediators Inflamm (2010) 0.90

The physiopathology of lipoprotein (a). Front Biosci (Schol Ed) (2010) 0.89

Antiproliferative effect of oleuropein in prostate cell lines. Int J Oncol (2012) 0.88

Glucoraphanin, the bioprecursor of the widely extolled chemopreventive agent sulforaphane found in broccoli, induces phase-I xenobiotic metabolizing enzymes and increases free radical generation in rat liver. Mutat Res (2006) 0.87

High hydrophobic amino acid exposure is responsible of the neurotoxic effects induced by E200K or D202N disease-related mutations of the human prion protein. Int J Biochem Cell Biol (2010) 0.86

One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease. Pharmacology (2010) 0.86

Relationship between plasma antioxidant concentrations and carotid intima-media thickness: the Asymptomatic Carotid Atherosclerotic Disease In Manfredonia Study. Eur J Cardiovasc Prev Rehabil (2009) 0.85

Antioxidant vitamin supplementation in asthma. Ann Clin Lab Sci (2007) 0.84

Leukotriene modifiers in the treatment of cardiovascular diseases. J Leukoc Biol (2008) 0.84

The role of selenium, zinc and antioxidant vitamin supplementation in the treatment of bronchial asthma: adjuvant therapy or not? Expert Opin Investig Drugs (2005) 0.84

Atherosclerosis: from biology to pharmacological treatment. J Geriatr Cardiol (2012) 0.83

Antioxidant vitamin supplementation in cardiovascular diseases. Ann Clin Lab Sci (2007) 0.83

Tapering dose of inhaled budesonide in subjects with mild-to-moderate persistent asthma treated with montelukast: a 16-week single-blind randomized study. Ann Clin Lab Sci (2005) 0.82

Arterial cord blood lutein levels in preterm and term healthy newborns are sex and gestational age dependent. Clin Biochem (2012) 0.82

Body cell mass measured by total body potassium in normal-weight and obese men and women. J Am Coll Nutr (2003) 0.81

Ivabradine: beyond heart rate control. Adv Ther (2009) 0.80

Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study. Expert Opin Pharmacother (2008) 0.80

Review: Pharmacological treatment of airway remodeling: inhaled corticosteroids or antileukotrienes? Ann Clin Lab Sci (2004) 0.80

Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension. Adv Ther (2009) 0.80

Calcium binding promotes prion protein fragment 90-231 conformational change toward a membrane destabilizing and cytotoxic structure. PLoS One (2012) 0.80

Seminal plasma total antioxidant capacity and semen parameters in patients with varicocele. Reprod Biomed Online (2009) 0.80

Is nasal polyposis a determinant of bronchial hyperresponsiveness and altered quality of life in asthmatic subjects? A case-control study. Ann Clin Lab Sci (2006) 0.80

The effect of pharmacological treatment on ADMA in patients with heart failure. Front Biosci (Elite Ed) (2011) 0.79

Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease. Expert Opin Pharmacother (2011) 0.79

Current status of measuring oxidative stress. Methods Mol Biol (2010) 0.78

Effect of Treatment with Cyanidin-3-O-β-D-Glucoside on Rat Ischemic/Reperfusion Brain Damage. Evid Based Complement Alternat Med (2012) 0.78

Effects of pleiotrophin overexpression on mouse skeletal muscles in normal loading and in actual and simulated microgravity. PLoS One (2013) 0.78

Peripheral biomarkers of oxidative stress and their limited potential in evaluation of clinical features of Huntington's patients. Biomarkers (2014) 0.78

Order effects of concurrent endurance and resistance training on post-exercise response of non-trained women. J Sports Sci Med (2012) 0.77

Green tea and its isolated constituents in cancer prevention. Mutat Res (2005) 0.77

Plasma antioxidants and asymptomatic carotid atherosclerotic disease. Ann Nutr Metab (2008) 0.77

Weight loss in obese prepubertal children: the influence of insulin resistance. Endocr Res (2012) 0.77

Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx mice. Lab Invest (2013) 0.77

Dimethylarginine dimethylaminohydrolase/nitric oxide synthase pathway in liver and kidney: protective effect of cyanidin 3-O-β-D-glucoside on ochratoxin-A toxicity. Toxins (Basel) (2012) 0.77

Vitamin C and E consumption and coronary heart disease in men. Front Biosci (Elite Ed) (2012) 0.76

The biological effect of pharmacological treatment on dimethylaminohydrolases (DDAH-1) and cationic amino acid transporter-1 (CAT-1) expression in patients with acute congestive heart failure. Microvasc Res (2011) 0.76

Securebox: a multibiopsy sample container for specimen identification and transport. Acta Cytol (2008) 0.75

Prevention of cardiovascular diseases with Carotenoids. Front Biosci (Schol Ed) (2017) 0.75

Review Article: Novel Therapeutic Strategies Against Cancer: Marine-derived Drugs May Be The Answer? Anticancer Agents Med Chem (2016) 0.75

Physical exercise reduces synthesis of ADMA, SDMA, and L-Arg. Front Biosci (Elite Ed) (2015) 0.75

[Duchenne muscular dystrophy: rational basis, state of the art]. Recenti Prog Med (2006) 0.75

An update of the leukotriene modulators for the treatment of asthma. Expert Opin Investig Drugs (2004) 0.75

Rosuvastatin effect on intima media thickness in adult vs elderly patients. Front Biosci (Elite Ed) (2012) 0.75

[Duchenne muscular dystrophy: perspectives of treatment]. Recenti Prog Med (2006) 0.75

[Antileukotrienes in the therapy of bronchial asthma]. Recenti Prog Med (2003) 0.75